Oncolytic viral therapy for pancreatic cancer: current research and future directions

被引：16

作者：

Ady, Justin W. ^{[1
]}

Heffner, Jacqueline ^{[1
]}

Klein, Elizabeth ^{[1
]}

Fong, Yuman ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA

来源：

ONCOLYTIC VIROTHERAPY | 2014年 / 3卷

关键词：

pancreatic cancer; oncolytic virus; review;

D O I：

10.2147/OV.S53858

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The development of targeted agents and chemotherapies for pancreatic cancer has only modestly affected clinical outcome and not changed 5-year survival. Fortunately the genetic and molecular mechanisms underlying pancreatic cancer are being rapidly uncovered and are providing opportunities for novel targeted therapies. Oncolytic viral therapy is one of the most promising targeted agents for pancreatic cancer. This review will look at the current state of the development of these self-replicating nanoparticles in the treatment of pancreatic cancer.

引用

页码：35 / 46

页数：12

共 120 条

[1] Oncolytic Adenoviruses Armed with Thymidine Kinase Can Be Traced by PET Imaging and Show Potent Antitumoural Effects by Ganciclovir Dosing [J].

Abate-Daga, Daniel ;

Andreu, Nuria ;

Camacho-Sanchez, Juan ;

Alemany, Ramon ;

Herance, Raul ;

Millan, Olga ;

Fillat, Cristina .

PLOS ONE, 2011, 6 (10)

[2] Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma [J].

Aguirre, AJ ;

Bardeesy, N ;

Sinha, M ;

Lopez, L ;

Tuveson, DA ;

Horner, J ;

Redston, MS ;

DePinho, RA .

GENES & DEVELOPMENT, 2003, 17 (24) :3112-3126

[3]

Allison DC, 1998, J SURG ONCOL, V67, P151, DOI 10.1002/(SICI)1096-9098(199803)67:3<151::AID-JSO2>3.0.CO

[4]

2-8

[5] Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV [J].

Angelova, Assia L. ;

Aprahamian, Marc ;

Grekova, Svitlana P. ;

Hajri, Amor ;

Leuchs, Barbara ;

Giese, Nathalia A. ;

Dinsart, Christiane ;

Herrmann, Alexia ;

Balboni, Ginette ;

Rommelaere, Jean ;

Raykov, Zahari .

CLINICAL CANCER RESEARCH, 2009, 15 (02) :511-519

[6] Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy [J].

Armstrong, Leonard ;

Arrington, Amanda ;

Han, Joohee ;

Gavrikova, Tatyana ;

Brown, Eric ;

Yamamoto, Masato ;

Vickers, Selwyn M. ;

Davydova, Julia .

AMERICAN JOURNAL OF SURGERY, 2012, 204 (05) :741-750

[7] Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer [J].

Bailey, Jennifer M. ;

Swanson, Benjamin J. ;

Hamada, Tomofumi ;

Eggers, John P. ;

Singh, Pankaj K. ;

Caffery, Thomas ;

Ouellette, Michel M. ;

Hollingsworth, Michael A. .

CLINICAL CANCER RESEARCH, 2008, 14 (19) :5995-6004

[8] Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse [J].

Bardeesy, N ;

Aguirre, AJ ;

Chu, GC ;

Cheng, KH ;

Lopez, LV ;

Hezel, AF ;

Feng, B ;

Brennan, C ;

Weissleder, R ;

Mahmood, U ;

Hanahan, D ;

Redston, MS ;

Chin, L ;

DePinho, RA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (15) :5947-5952

[9] Enhancement of NK cell antitumor responses using an oncolytic parvovirus [J].

Bhat, Rauf ;

Dempe, Sebastian ;

Dinsart, Christiane ;

Rommelaere, Jean .

INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (04) :908-919

[10] Validation of the 6th Edition AJCC Pancreatic Cancer Staging System - Report from the National Cancer Database [J].

Bilimoria, Karl Y. ;

Bentrem, David J. ;

Ko, Clifford Y. ;

Ritchey, Jamie ;

Stewart, Andrew K. ;

Winchester, David P. ;

Talamonti, Mark S. .

CANCER, 2007, 110 (04) :738-744

← 1 2 3 4 5 6 7 8 9 10 →